research chemical comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-09-25. Where a claim depends on a specific study, the study is described rather than over-claimed.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule ligand; not a hormone or peptide |
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| CAS Registry Number | 1379686-30-2 | Unique chemical identifier |
| Common synonyms | SR9009; stenabolic | Stenabolic is informal and not an official name |
| Reported targets | REV-ERBα and REV-ERBβ | Nuclear receptors linked to circadian and metabolic regulation |
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
The presence of breast implants currently presents no contraindication to breast feeding, and there is no evidence to support that the practice may present health issues to a breastfeeding infant. Women with breast implants may have functional breast-feeding difficulties; mammoplasty procedures that feature periareolar incisions are especially likely to cause breastfeeding difficulties. Surgery may also damage the lactiferous ducts and the nerves in the nipple-areola area. Functional breastfeeding difficulties arise if the surgeon cut the milk ducts or the major nerves innervating the breast, or if the milk glands were otherwise damaged. Milk duct and nerve damage are more common if the incisions cut tissue near the nipple. The milk glands are most likely to be affected by subglandular implants and by large-sized breast implants, which pinch the lactiferous ducts and impede milk flow. Small-sized breast implants and submuscular implantation cause fewer breast-function problems; however, it is impossible to predict whether a woman who undergoes breast augmentation will be able to successfully breast feed since some women are able to breast-feed after periareolar incisions and subglandular placement and some are not able to after augmentation using submuscular and other types of surgical incisions.
When making transmission measurements, the spectrophotometer quantitatively compares the fraction of light that passes through a reference solution and a test solution, then electronically compares the intensities of the two signals and computes the percentage of transmission of the sample compared to the reference standard. For reflectance measurements, the spectrophotometer quantitatively compares the fraction of light that reflects from the reference and test samples. Light from the source lamp is passed through a monochromator, which diffracts the light into a "rainbow" of wavelengths through a rotating prism and outputs narrow bandwidths of this diffracted spectrum through a mechanical slit on the output side of the monochromator. These bandwidths are transmitted through the test sample. Then the photon flux density (watts per meter squared usually) of the transmitted or reflected light is measured with a photodiode, CCD or other light sensor. The transmittance or reflectance value for each wavelength of the test sample is then compared with the transmission or reflectance values from the reference sample. Most instruments will apply a logarithmic function to the linear transmittance ratio to calculate the 'absorbency' of the sample, a value which is proportional to the 'concentration' of the chemical being measured. In short, the sequence of events in a scanning spectrophotometer is as follows:
==== Obsessive–compulsive disorder ==== Psilocybin has been studied for the treatment of obsessive–compulsive disorder. It is formally under development for treatment of OCD by multiple pharmaceutical companies. These include candidates with the developmental code names SYNP-101 (Ceruvia Lifesciences) and MLS-101 (MycoMedica Life Sciences).
=== Solvent process === The process involves transesterification of sucrose and triglycerides under a basic condition at 90 °C. DMF was used as a solvent at first, but was later substituted with dimethyl sulfoxide or DMSO, which is less hazardous and cheaper. This process produces a mixture of sucrose monoesters and more substituted esters at about a 5:1 ratio.
Sources: en.wikipedia.org
== Awards and honours == 2004 CWA Ian Fleming Steel Dagger Award shortlist for Dead I Well May Be 2007 Audie Award for Best Thriller/Suspense for The Dead Yard. 2008 Young Hoosier Award and Beehive Award shortlist for The Lighthouse Land 2009 World Book Day Award longlist for The Bloomsday Dead 2010 Spinetingler Award for Best Novel for Fifty Grand 2011 Theakston Old Peculier Crime Novel of the Year Award longlist for Fifty Grand 2013 Spinetingler Award for Best Crime Novel for The Cold Cold Ground 2013 Prix Du Meilleur Polar shortlist for The Cold Cold Ground 2013 Crime Fest Last Laugh Award shortlist for The Cold Cold Ground 2013 Ned Kelly Award for Best Crime Novel shortlist for I Hear the Sirens in the Street 2014 Barry Award (for crime novels)for Best Mystery Novel (Paperback Original) for I Hear the Sirens in the Street 2014 Grand Prix de Littérature Policière shortlist for I Hear the Sirens in the Street 2014 Theakston Old Peculier Crime Novel of the Year Award shortlist for I Hear the Sirens in the Street 2014 Ned Kelly Award for Best Fiction for In the Morning I'll Be Gone 2015 Audie Award For Best Thriller shortlist for In the Morning I'll Be Gone 2015 Prix SNCF Du Polar shortlist for The Cold Cold Ground 2015 Ned Kelly Award shortlist for Gun Street Girl 2015 Boston Globe Best Book of 2015 for Gun Street Girl 2015 Irish Times Best Crime Novel of 2015 for Gun Street Girl 2016 Edgar Award (Best Paperback Original) shortlist for Gun Street Girl 2016 Anthony Award (Best Paperback Original) shortlist for Gun Street Girl 2016 Audie Award for Best Mystery shortlist for Gun Street Girl 2016 Boston Globe Best Book of 2016 for Rain Dogs 2016 Irish Times Best Crime Novel of 2016 for Rain Dogs 2016 Theakston Old Peculier Crime Novel of the Year Award shortlist for Rain Dogs 2016 Ned Kelly Award shortlist for Rain Dogs 2016 CWA Ian Fleming Steel Dagger shortlist for Rain Dogs 2017 Edgar Award (Best Paperback Original) for Rain Dogs 2017 Barry Award for Rain Dogs 2017 Anthony Award (Best Paperback Original) for Rain Dogs 2017 Ned Kelly Award for Police at the Station and They Don't Look Friendly 2017 CWA Ian Fleming Steel Dagger Award shortlist for Police at the Station and They Don't Look Friendly 2017 Boston Globe Best Book of 2017 for Police at the Station and They Don't Look Friendly 2018 International Thriller Writers Awards (Best Paperback Original Novel) shortlist for Police at the Station and They Don't Look Friendly 2019 Time magazine Books of the Year for The Chain 2020 Theakston's Old Peculier Crime Novel of the Year Award 2020 winner for The Chain. 2020 Ian Fleming Steel Dagger Award longlist for The Chain; CWA Body in the Library longlist for The Chain 2020 International Thriller Writers Award for Best Hardcover Novel, The Chain. 2020 Ned Kelly Award for Best International Crime Fiction for The Chain. 2020 Macavity Awards for Best Mystery Novel by Mystery Readers International for The Chain. 2020 Barry Award (for crime novels) for Best Mystery Novel winner for The Chain. 2022 In The Morning I'll Be Gone winner of the Prix Polar Pourpres for Best Mystery Novel 2022 Best Thrillers of 2022 for The Island. New York Times 2023 Best Thrillers of 2023 for The Detective Up Late. Washington Post 2024 Barry Award (for crime novels) nominee for Best Mystery Novel for The Detective Up Late
=== Zeek Braverman === Ezekiel "Zeek" Braverman (Craig T. Nelson) is the patriarch of the Braverman family, Camille's husband and the father of Adam, Sarah, Crosby, and Julia. He has dabbled in various careers, including being a soldier in Vietnam, having graduated from West Point in the class of 1962 (although in the season two episode "A House Divided" he is shown telling his grandson Max about going into basic training at Fort Benning, Georgia, which would imply he was enlisted; also, he would have been 19 or 20 when graduating West Point), an activist hippie, an aspiring actor, and a shrewd entrepreneur, but none lasted more than a few years. He is 67 at the start of the series (as he is said to be turning 72 in season 6), making him four years older than his wife, Camille. In the first season, it is revealed that he made a bad investment, causing him and his wife, Camille, financial hardship. Later, it is also revealed that he had an affair. He doesn't get along with his mother, Blanche. She turns 86 in season three, which means that she was about seventeen when Zeek was born, as he would have been 69 in season three. Zeek's health begins to decline throughout season 6, and he endures two hospital stays. Zeek dies peacefully in his home an unknown time after Sarah's wedding to Hank as Camille is looking at photos taken by Max. His ashes are spread in the musical montage that begins the last scene of the series finale.
== Prognosis == Most skin grafts are successful, but in some cases grafts do not heal well and may require repeat grafting. The graft should also be monitored for good circulation. Recovery time from skin grafting can be long. Graft recipients wear compression garments for several months and are at risk for depression and anxiety consequent to long-term pain and loss of function.
Sources: en.wikipedia.org
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.
No. It has no approved medical indication, and human safety and efficacy data are limited. It appears in research chemical markets and is banned by some sports authorities.
Natural ligands include heme and certain metabolites; SR9009 is a synthetic small molecule with higher potency and selectivity in some assays. Its effects depend on cell type and timing. It is not a naturally occurring compound.
Liquid chromatography-tandem mass spectrometry is a common approach. It can detect the parent compound and its metabolites in biological matrices.